Correlation Between Pasithea Therapeutics and Bruker

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Bruker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Bruker into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Bruker, you can compare the effects of market volatilities on Pasithea Therapeutics and Bruker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Bruker. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Bruker.

Diversification Opportunities for Pasithea Therapeutics and Bruker

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pasithea and Bruker is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Bruker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bruker and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Bruker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bruker has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Bruker go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Bruker

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to under-perform the Bruker. In addition to that, Pasithea Therapeutics is 6.33 times more volatile than Bruker. It trades about -0.02 of its total potential returns per unit of risk. Bruker is currently generating about -0.13 per unit of volatility. If you would invest  7,067  in Bruker on August 28, 2024 and sell it today you would lose (1,177) from holding Bruker or give up 16.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy57.14%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  Bruker

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Bruker 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bruker has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward-looking signals remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pasithea Therapeutics and Bruker Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and Bruker

The main advantage of trading using opposite Pasithea Therapeutics and Bruker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Bruker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will offset losses from the drop in Bruker's long position.
The idea behind Pasithea Therapeutics Corp and Bruker pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated